{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:32:26Z","timestamp":1761060746156,"version":"3.32.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12350-019-01635-w","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T10:46:03Z","timestamp":1549449963000},"page":"2500-2502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["New insights for early assessment of cardiac involvement in Anderson-Fabry disease"],"prefix":"10.1016","volume":"28","author":[{"given":"Alberto","family":"Cuocolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmela","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Gaudieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Imbriaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-019-01635-w_bib1","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3733","article-title":"\u03b1-Galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1007\/s12350-019-01635-w_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1172-5-30","article-title":"Fabry disease","volume":"5","author":"Germain","year":"2010","journal-title":"Orphanet J Rare Dis."},{"key":"10.1007\/s12350-019-01635-w_bib3","doi-asserted-by":"crossref","unstructured":"Linhart A, Kampmann C, Zamorano JL, Sunder-Plassmann G, Beck M, Mehta A, et al. European FOS investigators. Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J. 2007;28:1228\u201335.","DOI":"10.1093\/eurheartj\/ehm153"},{"key":"10.1007\/s12350-019-01635-w_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/cge.12386","article-title":"The kidney in Fabry\u2019s disease","volume":"86","author":"Pisani","year":"2014","journal-title":"Clin Genet."},{"key":"10.1007\/s12350-019-01635-w_bib5","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-2362.2008.02053.x","article-title":"Cardiac performance during exercise in patients with Fabry\u2019s disease","volume":"38","author":"Spinelli","year":"2008","journal-title":"Eur J Clin Invest."},{"key":"10.1007\/s12350-019-01635-w_bib6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/heartjnl-2015-308494","article-title":"Cardiac involvement in genotype-positive Fabry disease patients assessed by cardiovascular MR","volume":"102","author":"Kozor","year":"2016","journal-title":"Heart."},{"key":"10.1007\/s12350-019-01635-w_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1750-1172-8-116","article-title":"Fibrosis: a key feature of Fabry disease with potential therapeutic implications","volume":"8","author":"Weidemann","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"10.1007\/s12350-019-01635-w_bib8","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/eurheartj\/eht098","article-title":"Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease","volume":"34","author":"Kr\u00e4mer","year":"2013","journal-title":"Eur Heart J."},{"key":"10.1007\/s12350-019-01635-w_bib9","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2214\/AJR.05.0442","article-title":"MRI characterization of myocardial tissue in patients with Fabry\u2019s disease","volume":"188","author":"Imbriaco","year":"2007","journal-title":"AJR Am J Roentgenol."},{"key":"10.1007\/s12350-019-01635-w_bib10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/hrt.2008.162800","article-title":"Effects of enzyme-replacement therapy in patients with Anderson-Fabry disease: a prospective long-term cardiac magnetic resonance imaging study","volume":"95","author":"Imbriaco","year":"2009","journal-title":"Heart."},{"key":"10.1007\/s12350-019-01635-w_bib11","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1259\/bjr\/52065763","article-title":"Cardiac magnetic resonance imaging illustrating Anderson-Fabry disease progression","volume":"83","author":"Imbriaco","year":"2010","journal-title":"Br J Radiol."},{"key":"10.1007\/s12350-019-01635-w_bib12","doi-asserted-by":"crossref","unstructured":"Moon JC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003;24:2151-5.","DOI":"10.1016\/j.ehj.2003.09.017"},{"key":"10.1007\/s12350-019-01635-w_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/10976640600605002","article-title":"The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease","volume":"8","author":"Moon","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1007\/s12350-019-01635-w_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","article-title":"Assessment of myocardial fibrosis with cardiovascular magnetic resonance","volume":"57","author":"Mewton","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-019-01635-w_bib15","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jacc.2008.03.018","article-title":"Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy","volume":"51","author":"Wu","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-019-01635-w_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cjca.2012.11.033","article-title":"The prognostic role of late gadolinium enhancement magnetic resonance imaging in patients with cardiomyopathy","volume":"29","author":"Stirrat","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1007\/s12350-019-01635-w_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcmg.2011.01.020","article-title":"Differences in Fabry cardiomyopathy between female and male patients: Consequences for diagnostic assessment","volume":"4","author":"Niemann","year":"2011","journal-title":"JACC Cardiovasc Imaging."},{"issue":"16","key":"10.1007\/s12350-019-01635-w_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12968-014-0099-4","article-title":"Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance","volume":"5","author":"Pica","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1007\/s12350-019-01635-w_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance non-contrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-019-01635-w_bib20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00259-015-3036-3","article-title":"First experience of simultaneous PET\/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease","volume":"42","author":"Nappi","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-019-01635-w_bib21","article-title":"Early cardiac involvement affects left ventricular longitudinal function in females carrying \u03b1-galactosidase A mutation: Role of hybrid positron emission tomography and magnetic resonance imaging and speckle-tracking echocardiography","volume":"11","author":"Spinelli","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-019-01635-w_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009052","article-title":"Immune-mediates myocarditis in Fabry disease cardiomyopathy","volume":"7","author":"Frustaci","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1007\/s12350-019-01635-w_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s12350-016-0697-7","article-title":"Myocardial 123I-MIBG scintigraphy in relation to markers of inflammation and long-term clinical outcome in patients with stable chronic heart failure","volume":"25","author":"Verschure","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1007\/s12350-019-01635-w_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00259-015-3273-5","article-title":"Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123) I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease","volume":"43","author":"Spinelli","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1007\/s12350-019-01635-w_bib25","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1007\/s00259-017-3778-1","article-title":"Cardiac sympathetic neuronal damage precedes myocardial fibrosis in patients with Anderson-Fabry disease","volume":"44","author":"Imbriaco","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-019-01635-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01635-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123016409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123016409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-019-01635-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T15:50:11Z","timestamp":1735573811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123016409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1071358123016409"],"URL":"https:\/\/doi.org\/10.1007\/s12350-019-01635-w","relation":{},"ISSN":["1071-3581"],"issn-type":[{"type":"print","value":"1071-3581"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights for early assessment of cardiac involvement in Anderson-Fabry disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-019-01635-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}